Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 16, 2024 05:00 ET | Source: ITM Isotope Technologies Munich SE

ITM Appoints Dr. Mark Harfensteller as Member of its Executive Board

Garching / Munich, Germany, January 16, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the appointment of Dr. Mark Harfensteller to its...
January 04, 2024 07:54 ET | Source: ITM Isotope Technologies Munich SE

ITM Announces Operational Readiness for NOVA Facility, the World’s Largest Lutetium-177 Production Site

Receipt of Radioactive Material Handling License (RAM License) for production of n.c.a. Lutetium-177Progress demonstrates company’s ability to rapidly increase GMP manufacturing capabilities to...
December 21, 2023 08:00 ET | Source: ITM Isotope Technologies Munich SE

ITM to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Garching / Munich, Germany, December 21, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that CEO, Steffen Schuster and CFO, Dr. Klaus...
December 14, 2023 09:28 ET | Source: ITM Isotope Technologies Munich SE

ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development and Commercialization of Folate-Based Radiotheranostics

ITM secures first-in-class folate precursors for radiolabeling to advance clinical and commercial development of its folate-based pipeline candidatesLicensing agreement broadens indication areas to...
December 14, 2023 09:26 ET | Source: ITM Isotope Technologies Munich SE

ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development and Commercialization of Folate-Based Radiotheranostics

ITM secures first-in-class folate precursors for radiolabeling to advance clinical and commercial development of its folate-based pipeline candidatesLicensing agreement broadens...
October 24, 2023 08:00 ET | Source: ITM Isotope Technologies Munich SE

ITM Reports on Participation at 3rd ICPO Forum for Theranostics in Precision Oncology and Announces Support for ICPO Academy for Theranostics

Garching / Munich, Germany, October 24, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today reported on its participation at the 3rd International...
October 18, 2023 08:00 ET | Source: ITM Isotope Technologies Munich SE

ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of Actinium-225

New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale quantities of rare medical isotope ...
July 31, 2023 09:00 ET | Source: ITM Isotope Technologies Munich SE

ITM and POINT Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177

Garching / Munich, Germany and Indianapolis, IN, USA, July 31, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company and POINT Biopharma Global Inc. (NASDAQ:...
June 15, 2023 04:23 ET | Source: ITM Isotope Technologies Munich SE

ITM to Host Theranostics Symposium on Clinical Need and Supply at SNMMI Annual Meeting on Sunday, June 25, 2023

Garching / Munich, June 15, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host a multidisciplinary symposium titled,...
June 13, 2023 02:00 ET | Source: ITM Isotope Technologies Munich SE

ITM Opens World's Largest Lutetium-177 Production Facility for Targeted Radionuclide Therapies Against Cancer

New manufacturing plant in Neufahrn near Munich increases ITM's production capacity tenfoldCeremonial opening by Minister of State, Dr. Florian Herrmann, Head of the Bavarian State Chancellery ...